Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CHIEF LEGAL OFFICER

CHIEF FINANCIAL OFFICER

Chief Legal Officer

Chief Medical Officer

Chief Financial Officer

COO, General Counsel

Interim CEO

President, CEO

AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 trial for the treatment of generalized pustular psoriasis; Rosnilimab, an anti-PD-1 agonist antibody program designed to suppress T-cell driven inflammatory diseases by augmenting signaling through PD-1 or targeted depletion of PD-1+ T cells; and ANB032, an anti-BTLA modulator antibody applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation. The company also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. and Bristol-Myers Squibb; and license agreements with United Kingdom Research and Innovation, as well as Millipore Corporation. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.

AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-26	Premium	sold (taxes)	Premium	Premium	Premium	CEO
2024-03-25	Premium	sold	Premium	Premium	Premium	CEO
2024-03-22	Premium	sold	Premium	Premium	Premium	CEO
2024-02-16	Premium	sold	Premium	Premium	Premium	CHIEF LEGAL OFFICER
2024-02-16	Premium	acquired	Premium	Premium	Premium	CHIEF LEGAL OFFICER
2024-01-30	Premium	sold	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-01-08	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2024-01-08	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-01-08	Premium	sold	Premium	Premium	Premium	CEO
2024-01-08	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-01-06	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-01-06	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2024-01-06	Premium	acquired	Premium	Premium	Premium	CEO
2024-01-06	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-11-22	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2023-09-18	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-09-18	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2023-09-14	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-09-14	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2023-09-14	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2023-09-14	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-09-14	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-09-14	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2022-08-08	Premium	sold	Premium	Premium	Premium	COO, General Counsel
2022-06-08	Premium	sold	Premium	Premium	Premium	COO, General Counsel

ANAB - AnaptysBio Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for ANAB